Clinical trial Recruiting at 1 site Interventional Ages 6 to 14

Child-friendly RTM therapy to reduce PTSD symptoms

Official title: Developing Innovative PTSD Treatment for Children: Reconsolidation of Traumatic Memories Protocol™ for Children (RTM-C Protocol)

Run by Global Institute for Mental Health Innovations, Networking and Development a.s.b.l. · NCT07185126 · Data updated 2026-11-12

This project will test whether a child-friendly Reconsolidation of Traumatic Memories protocol (RTM-C) can safely reduce PTSD symptoms in children aged 6–14 who have experienced trauma.

Quick facts

Study typeInterventional
Ages6 Years to 14 Years
SexAll
Enrollment40 (estimated)
SponsorGlobal Institute for Mental Health Innovations, Networking and Development a.s.b.l.
Academic / other
Locations1 site (Kyiv)
StatusRecruiting
StartedSeptember 20, 2025
Main results expectedFebruary 20, 2027
Study endsAugust 20, 2027
Registry record updatedSeptember 16, 2026
Trial IDNCT07185126 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Children aged 6–14 with clinically significant PTSD symptoms (CATS-2 parent total ≥15), endorsed functional impairment, available caregiver consent, and ability to attend the parent session, six treatment sessions, and follow-ups are ideal candidates.

Probably not a fit

Children with acute comorbid psychiatric disorders, those already in concurrent trauma-focused psychotherapy, or those unable to follow session instructions due to cognitive impairment are unlikely to benefit from this protocol.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The RTM-C protocol adapts an adult memory reconsolidation therapy into child-friendly language, games, and animated tools to help children safely reprocess traumatic memories. Children and a caregiver attend an initial parent session, then the child receives up to six therapist-led sessions that use guided imagery and dissociative/regulatory steps. Outcomes include symptom change measured by parent-reported CATS-2, safety, and acceptability to children, parents, and therapists, with 1- and 6-month follow-ups. The intervention is brief, non-pharmacological, and delivered in-person at a single site.

Why it matters

Potential benefit: If successful, RTM-C could quickly reduce distressing memories, flashbacks, and nightmares and improve daily functioning for children with PTSD.

How similar studies have gone: The adult RTM Protocol™ has demonstrated strong clinical effectiveness in several trials, but the child-adapted RTM-C is novel and has limited prior testing.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age 6-14 years at enrolment.
* PTSD symptoms present: CATS-2 (Parent) total ≥15 at screening.
* Functional impact: impairment endorsed in ≥1 CATS-2 domain (relationships, leisure, learning, happiness).
* Consent/assent: written parent/guardian consent and child assent obtained.
* Availability: child and caregiver can attend parent session + 6 treatment sessions and complete 1- and 6-month follow-ups.
* Language/comprehension: child can understand session instructions and participate in tasks (with supports as needed).
* Therapist check of readiness: during Session 1 practice, child demonstrates reliable break state (disengages from imagery, re-orients to present, maintains eye contact, relaxed affect).

Exclusion Criteria:

* Acute comorbid mental disorder.
* Concurrent trauma-focused psychotherapy planned or ongoing during the study period.
* Inability to understand/follow instructions due to cognitive impairment or other reasons that preclude participation.
* Medical/neurological condition or situational factors (e.g., inability to commit to visits) that, in the investigator's judgment, would make participation unsafe or compromise study integrity.

Where it's running

  • Charitable Foundation Voices of Children
    Kyiv, Ukraine
    Recruiting

Study contacts

  • Principal investigator: Viktoriia Gorbunova, ScD — Global Institute for Mental Health Innovations, Networking and Development
  • Study coordinator: Viktoriia Gorbunova, ScD
  • Email: viktoriyka.gorbunova@gmail.com
  • Phone: +380931316322

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

  • Non-invasive vagus nerve stimulation (gammaCore) for PTSD

    This study will test whether the handheld gammaCore device, which delivers mild electrical stimulation to the vagus nerve through the neck, can help adults with PTSD reduce their symptoms.

    Recruiting Acacia Clinics · Sunnyvale, California · NCT07523685

  • Building Ukraine's strength in PTSD treatment

    This project will try the Reconsolidation of Traumatic Memories (RTM) protocol alongside standard PTSD treatments to see if it reduces symptoms in adults with PTSD living in Ukraine.

    Recruiting at 2 sites University of Luxembourg · Kyiv and 1 other locations · NCT07318181

  • Emotional dysregulation in adolescents with complex trauma traits

    Researchers will observe teens to see how emotional dysregulation shows up in CPTSD and how it differs from BPD and PTSD.

    Recruiting University Hospital, Strasbourg, France · Strasbourg, Grand Est · NCT07794332

  • Grappling with Trauma: BJJ for First Responders

    This program tests whether eight weeks of Brazilian Jiu-Jitsu can be tied to changes in trauma-related symptoms for first responders who prefer movement-based activities over traditional mental health services.

    Recruiting Sam Houston State University · Conroe, Texas · NCT07783516

  • Eye Movement Intervention with Different Memory Reactivation Procedures for Intrusive Traumatic Memories

    This online trial tests whether combining eye movements with different memory reactivation tasks can reduce intrusive trauma memories in people with PTSD.

    Recruiting Shaanxi Normal University · Xi'an, Shaanxi · NCT07767396

  • Trauma-informed Psilocybin-assisted psychotherapy for PTSD

    This study tests whether adding psilocybin to trauma-focused psychotherapy helps people with PTSD see if the approach is safe and tolerable and whether symptoms improve.

    Recruiting Early Phase 1 Tel-Aviv Sourasky Medical Center · Tel Aviv · NCT07737054

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.